UNSPSC 51295103: Dazadrol

This classification denotes an antidepressant agent with the molecular formula C15H14CLN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9U27285V5R chemically known as 2-pyridinemethanol, .alpha.-(4-chlorophenyl)-.alpha.-(4,5-dihydro-1h-imidazol-2-yl)- but generally known as dazadrol, which bears US NIH Compound Identifier 32940. European Medicines Agency schedules Dazadrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06918MIG.

UNSPSC 51295103 Dazadrol, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single identified opportunity — Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems — solicits emergency-response pharmaceuticals and medical equipment, not dazadrol or any pharmaceutical matching the code's stated name. The mismatch suggests either a tagging error in the source system or that this code sees little activity in state and local procurement channels that match its nominal scope.

Seminole County's July 2026 IFB sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year initial term with one-year renewal option, with quarterly deliveries to the county health building in Sanford. The procurement included standard requirements for drug-free workplace certification, E-Verify compliance, workers' compensation insurance, and commercial general liability coverage, with potential FEMA funding introducing federal compliance obligations. No explicit set-aside designations were noted. The lack of additional recent opportunities under this Commodity code and the category mismatch suggest limited current activity or misclassification in state and local procurement systems.